Home India Ministry of Health and Family Welfare Proposal invited for designation of Central Medical Device t...
Date: 2018-03-01 Category: Not Applicable State: Union Government Country: India

Proposal invited for designation of Central Medical Device testing lab for Medical devices including In-Vitro Diagnostic medical Device under Medical Devices Rules, 2017

Issued by Ministry of Health and Family Welfare · Central Drugs Standard Control Organization

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • The gazette notification invites proposals from NABL accredited laboratories for designation as Central Medical Device Testing Laboratories under the Medical Device Rules, 2017. This designation allows these laboratories to conduct tests and evaluations of medical devices, including In-Vitro Diagnostics (IVDs), on behalf of stakeholders and regulators.
  • The CDSCO aims to update its information on laboratories involved in testing medical devices and IVDs to make informed decisions on performance evaluation of these products.

Key Changes

  • NABL accredited laboratories with the capacity to test and evaluate medical devices and IVDs are encouraged to register with CDSCO and provide details of their activities.
  • Laboratories willing to be designated as Medical Device Testing Laboratories must communicate details about the Medical Devices/IVDs they can test, along with the personnel involved in testing.
  • Laboratories involved in Medical device/IVD's testing on the behalf of stakeholder are required to get registered under Rules 81-86 of chapter X of MDR-2017.
  • Interested laboratories must forward their proposals along with the documents/information listed in Annexure-1 to CDSCO by March 15, 2018.
  • Rule 19 in chapter-III, of Medical Device Rule, 2017, prescribes that the Central Government may, by notification, designate any laboratory having facilities for carrying out test and evaluation of Medical Devices including In vitro Diagnostics medical device, as Central Medical Devices Testing Laboratory for the above mentioned purposes with the proviso that no Medical device Testing laboratory, shall be so designated unless it has been duly accredited by the National accreditation Board for testing and calibration laboratories (i.e. NABL).

Impact Analysis

NABL Accredited Laboratories

  • Action Item: Assess capabilities against the requirements in Annexure-1, prepare the necessary documentation, and submit a proposal to CDSCO by the deadline.

Medical Device and IVD Manufacturers/Stakeholders

  • Action Item: Monitor the list of designated laboratories and incorporate them into testing and evaluation processes.

CDSCO/CLAISLA

  • Action Item: Establish a process for evaluating proposals, conducting inspections, and officially designating laboratories.

State/UT Drugs Controllers and CDSCO Zonal Offices

  • Action Item: Assist laboratories in their respective regions with the application process and ensure compliance with the requirements.

Key Entities Referenced

CDSCO: Central Drugs Standard Control Organization, the national regulatory body for pharmaceuticals and medical devices in India. NABL: National Accreditation Board for Testing and Calibration Laboratories, the accreditation body for testing and calibration laboratories in India. Medical Device Rules, 2017: The regulatory framework governing medical devices and IVDs in India, effective from January 1, 2018. MOHFW: Ministry of Health and Family Welfare, Government of India CLAISLA: An organization associated with CDSCO, likely involved in laboratory accreditation and standards.
Official Source Record View Original Source →
See Full Document Text
/ F. No. IVD/Misc/030/DCGI/18 Government of India Central Drugs Standard Control Organization FDA Shawan, Kotla Road, New Delhi-110002 201 Dated: Sub Proposal invited for Designation of Central Medical Device Testing Lab for Medical Devices including In-Vitro Diagnostic Medical Device under Medical Device Rules, 2017-regarding. It is desired in light of new Medical Device Rules-2017, published vide MOHFW notification No GSR 78(E) dated 31st January, 2017 effective from dated 1st January 2018 that CDSCO/CLAISLA shall have updated information of laboratories involved in testing of medical device & in vitro diagnostics, as based on these laboratory reports, decision on performance evaluation of these products are made by sta keholder/reg u later. In this regard, it is also required to get such laboratories shall get registered under Rules 81-86 of chapter X of MDR-2017, if they are involved in Medical device/lVD's testing on the behalf of stakeholder. Further, Rule-19 in chapter-III, of Medical Device Rule, 2017, prescribes that the Central Government may, by notification, may also designate any laboratory having facilities for carrying out test and evaluation of Medical Devices including In vitro Diagnostics medical device, as Central Medical Devices Testing Laboratory for the above mentioned purposes with the proviso that no Medical device Testing laboratory, shall be so designated unless it has been duly accredited by the National accreditation Board for testing and calibration laboratories (i.e. NABL). Therefore, NABL Accredited laboratories which are having capacity & capability for testing & evaluation of the Medical device including In Vitro Diagnostics may get registered with CDSCO & inform details of their activities. Similarly those labs, who are willing to get designated as Medical Device Testing Laboratories under said rules shall communicate their details about which Medical Device/IVD's can be tested at their laboratories along with person involved in the testing. This information is being sought in light of MDR-2017 & those labs which are found suitable may officially be designated as Central Medical Device testing lab for the purpose of testing & evaluation. Details/Proposal in this regard, along with the copy of documents/information listed in Annexure-1 may be forwarded to this office (Central Drugs Standard Control Organization, Medical Device & Diagnostic Division, FDA Bhawan, Kotla Road, New Delhi-110002 as well as mail on dci@nic in and ddcimd-cdsco@nic.in by 15st Mar. 2018. ~ r- (Dr. S Eswara Reddy) Drugs Controller General (India) To 1. All NABL Accredited laboratories involved in testing of medical device including In Vitro Diagnostics 2. All Association for Medical Device & In vitro Diagnostics. 3. IDMAlOPPI/IPA 4. All State/UT's Drugs Controller/ All Zonal and Sub Zonal Office of CDSCO with request to coordinate & facilitate the process of labs identification/registration/designation as mentioned above 5 . CDSCO Website for information for all stake holder •F. No. IVD/Misc/030IDCGI/18 Annexure-1 1. Covering Letter mentioning the Name & address of testing Institute/Hospital/diagnostic lab on the letter head, duly sign and stamped by the Director/Head of Organisation 2. Self attested copy of authorization letter to the person issued by the Director/ Company Secretary/ Partner/ Owner 3. Valid copy of NABL Certificate along with the annexure (Scope of test for which it is accredited) 4. Copy of testing Protocol and testing method for each of the testing parameter 5. List of Equipments/Apparatus/lnstruments/Analysera long with the calibration status and manufacturer details 6. Number of sample required for each testing along with proposed testing fee 7. Time duration for the testing report 8. Name & Designation of the competent person for each of testing including his/her Qualification, experience in relevant testing 9. Expression of Interest (EOI) - that you would like to be designated as Medical Device or In Vitro Diagnostic Testing Laboratory. Note: All information provided shall be authenticate & verifiable. Further applicant shall willing to sign agreement that there will not be conflict of interest for purpose of testing & evaluation. Additionally applicant may also provide any additional information describing operational ability/other accreditation/ approval/licenses/agreement held by applicant for testing facility.

Continue your research